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Abstract: The extraction, fractionation and recognition of flavonoids from the ethanolic extract of young twigs and 
leaves of C. bonduc were carried out. In addition, cytotoxic study of the flavonoids on two cancer cell lines, BGC-823 
and HeLa was carried our using sulphorhodamine B assay. Seven flavonoids, six of which are being reported for the first 
time in this plant, were isolated. Their structures were identified by MS and NMR spectroscopic methods. Petroleum 
ether, ethyl acetate and water fractions exhibited moderate cytotoxic activity against HeLa cells. Five compounds 
showed cytotoxic activity against HeLa cell in comparison with Paclitaxel, while only one compound showed a good 
degree of cytotoxic activity against BGC-823 cell in comparison to Paclitaxel. The results obtained showed a structure - 
activity relationship. 
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INTRODUCTION 
 
The second leading cause of death in the United States of 
America is cancer; this is exceeded only by 
cardiovascular disease (Jemal et al., 2005). Since 1990, 
cancer incidence has resulted in a 22% increase in death 
rate in the four most frequent cancers namely, stomach, 
colorectal, lung and breast (Parkin et al., 2001). In the 
year 2000, more than nine million new cases of cancer 
were reported, resulting in, over six million death (Parkin 
et al., 2001). Caesalpinia bonduc, (family: 
Caesalpiniaceae, genus Fabaceae), commonly known as 
Gray Nicker nut (English) and Ayo (Yoruba, Nigeria), is 
a prickly shrub with a hard, grey, globular shaped and 
smooth shining surface seeds (Nadkarni, 1954). It is a 
medicinal plant predominantly dispersed in the tropical 
and subtropical parts of Africa, Asia and the Caribbean 
(Gupta et al., 2003). It has a lot of applications in folk 
medicine.  
 
The pharmacological screening of the plant extracts 
reveals their anticancer, antioxidant, antimalarial, 
antihyperglycemic, anti-inflammatory, antirheumatic, 
antipyretic and anticonvulsant activities (Adesina, 1982; 
Gupta et al., 2004; Sonibare et al., 2009). Jäger and Saaby 
(2011), recently reported the anti-depressant, anti-anxiety, 
memory inducer and relaxing enhancer of C. bonduc. 
Previous investigations on the phytochemical constituents 
from C. bonduc has led to the isolation of various 
compounds including Bonducellin (Purushothaman et al., 
1982), Caesalpinia-F (Pascoe et al., 1986), 
Bonducellipins-A to -D (Peter et al., 1997), Caesalpin-G 
and -H (Peter et al., 1998), Caesalpinolide-A to -E (Yadav 
et al., 2007; Yadav et al., 2009) and others. As a result of 
the reported anticancer activity of C. bonduc against 
Ehrlich ascites carcinoma (Gupta et al., 2004) and the 
dearth of information on its bioactive constituents from 
Nigeria, this research work was proposed and 
implemented. This article describes the in vitro cytotoxic 
activity of extracts and flavonoids isolated from young 
twigs and leaves of C. bonduc obtained from Nigeria 
against BGC-823 (Human gastric carcinoma) and HeLa 
(Human cervical adenocarcinoma) cell lines.  
  
MATERIALS AND METHODS 
 
Plant material 
Young twigs and leaves of C. bonduc (Linn) Roxb. were 
collected from Forestry Research Institute of Nigeria 
(FRIN), Ibadan, Oyo state, Nigeria. Plant identification 
was done by Dr. Conrad Omonhinmi, Department of 
Biological Sciences, College of Science and Technology, *Corresponding author: e-mail: nhtan@mail.kib.ac.cn 
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Covenant University, Ota, Ogun state, Nigeria. 
Authentication and voucher referencing were carried out 
at FRIN with voucher specimen SHI108408 deposited in 
their Herbarium.  
 
Reagents, equipments and cell lines 
The reagents were of analytical grade. Paclitaxel, 
trichloroacetic acid (CCl3COOH), glacial acetic acid and 
sulforhodamine B were bought from Sigma Chemicals (St 
Louis, MO, USA). Records of 1H and 13C NMR spectra 
were carried out on Bruker DRX-500 or 400 
spectrometers (Bruker, Karlsruhe, Germany). 
Tetramethylsilane (TMS, SiCH3) was used as internal 
standard; chemical shift (δ) and coupling constant (J) 
were measured in ppm and Hz respectively. Positive 
Electron Spray Ionization Mass Spectroscopy (ESI-MS) 
spectra were recorded on API Qstar time of flight pulsar 
instrument (Applied Biosystems, USA). Column 
chromatography (cc) was carried out over LH-20 
Sephadex (Pharmacia Fine Chemical Co. Sweden) and 
silica gel (100 to 200, 200 to 300 mesh and 10 to 40µL, 
Qingdao Marine Chemical, Inc, China). Medium pressure 
liquid chromatography (MPLC) was carried out over 
Lichroprep Reverse phase gel RP - 18 (40-63 µm, Merck, 
Darmstadt, Germany). High-pressure liquid 
chromatography (HPLC) (HP Agilent 1100, Agilent 
Technologies, USA) was carried out over YMC-Pack 
ODS-A column. BGC-823 and HeLa cells were received 
from the Shanghai Institute of Materia Medica, Chinese 
Academy of Sciences (CAS), Shanghai, China. Cancer 
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Fig. 1: Chemical structures of compounds 1 – 7 isolated from C. bonduc 
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cell lines were cultivated in RPMI 1640 medium 
supplemented with 10% fetal blood saline (FBS) under a 
moisturised atmospheric state of 5% CO2 at 37oC. 
Solvents were sterilised by filtering with 0.22 micron-
pore Millipore filter in aseptic operation. Samples were 
prepared as stock solution by aseptic dissolution in 
dimethyl sulfoxide to concentration of 2.5mg/ml.  
 
Fig. 2: The graph of percentage cell viability (Y axis) 
against concentrations of solvent fractions of C. bonduc 
(X axis) showing the cytotoxic effect of solvent fractions 
on HeLa cells. The values were presented as absorbance 
values ± standard deviation of triplicate experiments. 
 
Fig. 3: The graph of percentage cell viability (Y axis) 
against concentrations of flavonoids (X axis) showing the 
cytotoxic effect of flavonoids on HeLa cells in 
comparison with Paclitaxel (Taxol). Compounds 6 and 7 
have no inhibitory activity at the highest tested dose 
hence, they were not evaluated for further cytotoxic 
assessment. The values were presented as absorbance 
values ± standard deviation of triplicate experiments.  
 
Extraction and fractional process of the plant 
The young twigs and leaves of the plant collected were air 
dried at room temperature and powdered. Powdered plant 
(8.8kg) was extracted with 75% v/v ethanol (50L), at 
normal room temperature (25oC), by maceration for 72 
hours using three consecutive extractions. The total 
filtrate was concentrated to dryness with rotary evaporator 
at 50oC. The dried ethanolic extract of the plant (1120g) 
was re-suspended in distilled water (H2O) and partitioned 
in sequence on petroleum ether, ethyl acetate, and n-
butanol. The different solvent fractions were concentrated 
with rotary evaporator to yield H2O-soluble fraction 
(630g), petroleum ether-soluble fraction (150g), n-
butanol-soluble fraction (170g) and ethyl acetate-soluble 
fraction (120g). Each fraction was subjected to cytotoxic 
activity determination.  
 
Fig. 4: The graph of percentage cell viability (Y axis) 
against concentrations of flavonoids (X axis) showing the 
cytotoxic effect of flavonoids on BGC-823 cells in 
comparison with Paclitaxel (Taxol). Compounds 6 and 7 
have no inhibitory activity at the highest tested dose 
hence; they were not evaluated for further cytotoxic 
assessment. The values were presented as absorbance 
values ± standard deviation of triplicate experiments.  
 
Purification and isolation of compounds 
Experimental procedure of purification and isolation of 
compounds were described in the supplementary section 
of the Journal.  
 
In vitro cytotoxic assay 
The method of sulphorhodamine B (SRB) assay as 
described by Tang et al., 2010, was followed for a 
quantitative measurement of cell viability and maturation. 
Cultivated cancer cells in RPMI 1640 culture medium 
(Sigma), were seeded in aliquot part of 90µl in a 96-well 
microtiter plates at 4×104 cells/well. After twenty-four 
hours of culture, the microtiter plates were made up to 
100µl with samples to the final concentrations of 10 
µg/ml for pure compounds and 40µg/ml for solvent 
fractions. The mixture was incubated for two days. 
Fixation of cells were carried out by adding 25µl of 80% 
ice-cold trichloroacetic acid (CCl3COOH, TCA) to each 
well, followed by incubation for 5 minutes and 
refrigeration at 4oC for one hour. Thereafter, the plates 
were rinsed, air-dried and stained with 100µl of 
Sulforhodamine B (SRB) (1% glacial acetic acid with 
0.4% SRB) for 15 minutes. Washing to remove excess 
dye was carried through with the addition of 1% glacial 
acetic acids. Stained SRB cells were dissolved by the 
addition of Tris (100µl of 10mM) to each well. The 
absorbance of the plates carried out using a micro-plate 
spectrometer (Molecular Devices, SPECTRA MAX 340, 
USA) at 560 nm. Advance judgment was carried through 
using four different concentrations (dilution proportion 
1:2) for samples with percentage inhibition (I%) of 50% 
and above, to calculate the IC50 rate (50% inhibitory 
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concentration). Cell growth suppression rates were 
showed as IC50. A clinically used anticancer agent, 
Paclitaxel, was utilised as a positive control. 
 
RESULTS  
 
Fig. 1 illustrates the seven flavonoids (1 - 7) that were 
separated from the crude ethanolic extract of C. bonduc. 
Fig. 2 depicts bar chart illustrating the percentage 
viability of HeLa cells on solvent fractions of C. bonduc. 
Table 1 shows that cytotoxic activity (IC50) of solvent 
fractions and compounds isolated from ethanolic extract 
of C. bonduc. Petroleum ether, water, compounds 1 - 5) 
and Taxol exhibited different levels of cytotoxic activities 
on HeLa cell lines with half maximum inhibitory 
concentration (IC50) values ranging from 32 to 1.022 
µg/mL while only compound 3 and Taxol exhibited 
cytotoxic activity on BGC 823 cell lines. Figs. 3 and 4 
illustrate the effect of flavonoids isolated from C. bonduc 
on viability of HeLa and BGC-823 cells respectively.  
 
DISCUSSION 
 
Compound 1 was separated as a pale yellow crystalline 
solid with yield of 319.30 mg. Its chemical formula was 
ascertained to be C17H14O4, on the ground of the 
molecular ion peak of positive ESI-MS m/z 305 [M+Na]+. 
Compound 1 was elucidated as 7-hydroxy-4'-methoxyl-
3,11-dehydrohomoisoflavanone (fig. 1). The 1D 1H and 
13C NMR spectra data (table S1) were in accord with 
published work (Purushothaman et al., 1982). Compound 
2 was separated as a pale yellow powder with yield of 
15.60 mg. Its chemical formula was ascertained to be 
C16H14O4, on the ground of the molecular ion peaks of 
positive ESI-MS m/z 271 [M+H]+ and 293 [M+Na]+. 
Compound 2 was identified as 4,4'-dihydroxy-2'-
methoxy-chalcone (fig. 1). Its 1D 1H and 13C NMR 
spectra data (table S2) were in accord with published 
work (Namikoshi et al., 1987a). Compound 3 was 
separated as a pale yellow powder of 10.4mg yield. Its 
chemical formula was observed to be C16H12O4, on the 
ground of the molecular ion peak of positive ESI-MS m/z 
269 [M+H]+. Compound 3 was identified as 7,4'-
dihydroxy-3,11-dehydrohomoisoflavanone (fig. 1). The 
1H and 13C NMR spectra data (table S1) were marked 
with close similarity with those of compound 1. The data 
were in agreement with published work (Namikoshi et al., 
1987b).  
 
Compound 4 was separated as a pale yellow powder like 
compounds 2 and 3 with yield of 12.80 mg. Its chemical 
formula was observed as C15H10O6 from its molecular ion 
peak at positive ESI-MS m/z 287 [M+H]+. Compound 4 
was elucidated as Luteolin (fig. 1). The 1H and 13C NMR 
spectra data (table S3) were in accord with published 
work (Wagner and Chari, 1976). Compound 5 was 
separated as a pale yellow crystalline solid with yield of 
227.00mg. Its chemical formula was observed to be 
C16H12O7, on the ground of the chemical ion peak at 
positive ESIMS m/z 317 [M+H]+. Compound 5 was 
elucidated as quercetin-3-methyl ether (fig. 1). The 1H 
and 13C NMR spectra data (table S3) were in accord with 
published work (Jurd and Horowitz, 1957).  
 
Compound 6 was separated as a brown paste with yield of 
24.40 mg. Its chemical formula was observed to be 
C20H18O10, on the ground of the molecular ion peak at 
positive ESI-MS m/z 441 [M+Na]+. Compound 6 was 
elucidated as kaempferol-3-O-β-D-xylopyranoside (fig. 
1). The 1H and 13C NMR spectra data (table S4) were in 
Table S1: 1H and 13C-NMR spectral data for compounds 1 and 3 (δ in ppm, J in Hz)  
 
Compounds δC δH δC δH 1 3 
2 67.53 5.35 (2H, d, J = 1.5) 69.05 5.35 (2H,br, s) 
3 126.50 - 127.07 - 
4 179.52 - 183.06 - 
5 129.39 7.73 (1H, d, J = 8.5) 130.69 7.80(1H,d,J=8.0) 
6 111.13 6.54 (1H, dd, J = 8.5, 2.0) 112.16 6.52 (1H, d, J = 8.0) 
7 164.61 - 166.69 - 
8 102.41 6.31 (1H, d, J = 2.0) 103.60 6.31 (1H, br, s) 
9 162.47 - 164.85 - 
10 114.30 - 115.90 - 
11 135.21 7.63 (1H, br, s) 138.16 7.71 (1H, s) 
1' 128.82 - 129.56 - 
2' 132.19 7.39 (2H, d, J = 8.5) 133.50 7.25 (2H, d, J= 7.6) 
3' 114.23 7.04 (2H, d, J = 8.5) 116.70 6.88 (2H, d, J= 7.6) 
4' 160.26 - 160.53 - 
5' 114.23 7.04 (2H, d, J = 8.5) 116.70 6.88 (2H,d, J=7.6) 
6' 132.19 7.39 (2H, d, J = 8.5) 133.50 7.25 (2H,d, J=7.6) 
4'-OCH3 55.33 3.81 (3H, s) - - 
1H NMR and 13C NMR were recorded at 500 and 125 MHz respectively in DMSO-d6. 
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accord with published work (Kruglii and Glyzin, 1968). 
Compound 7 was separated as a pale yellow crystalline 
solid like compounds 1 and 5, with yield of 79.50 mg. Its 
chemical formula was observed to be C26H28O14, on the 
ground of the molecular ion peak at positive ESIMS m/z 
565 [M+H]+. Compound 7 was identified to be 
Kaempferol-3-O-α-L-rhamnopyranosyl-1→2)-β-D-
xylopyranoside (fig. 1). The 1H and 13C NMR spectra data 
were (table S4) in accord with published work (Moon et 
al., 2010).  
 
Table S2: 1H and 13C-NMR spectral data for compound 2 
(δ in ppm, J in Hz) 
 
Compounds δC δH 2 
1 128.04 - 
2 131.38 7.50 (2H, d, J = 8.4) 
3 116.87 6.82 (2H, d, J = 8.4) 
4 161.21 - 
5 116.87 6.82 (2H, d, J = 8.4) 
6 131.38 7.50 (2H, d, J = 8.4) 
7 144.16 7.56 (1H, d, J = 15.6) 
8 125.07 7.41 (1H, d, J = 15.6) 
9 193.16 - 
1' 121.76 - 
2' 162.53 - 
3' 100.11 6.51 (1H, br s) 
4' 164.49 - 
5' 108.91 6.45 (1H, d, J = 8.4) 
6' 133.73 7.57 (1H, d, J = 8.4) 
2'-OCH3 56.14 3.88 (3H, s) 
1H NMR and 13C NMR were recorded at 500 and 125 MHz 
respectively in DMSO-d6. 
 
Table 1 indicates that compounds 1-5 showed good 
cytotoxic inhibition in their activities as indicated by their 
IC50 values while only compound 3 showed good 
cytotoxic inhibition against BGC-823 cells. On the other 
hand, compounds 6 and 7 showed insignificant inhibition 
(IC50 >10µg/mL) in both cell lines. The cytotoxicity result 
of compounds 4 and 5 are supported by the reports by 
Rubio et al., (2006) and Kawaii et al., (1999). However 
Rubio et al. (2006), reported that Kaempferol-3-methyl 
ether has cytotoxic activity with IC50 value of 35µM on 
HeLa cells while its glycones (compounds 6 and 7) lack 
cytotoxic activity. It is suggested that the lack of cytotoxic 
activity by compounds 6 and 7 might be due to the 
additional sugar moiety attached at position 3 of the C-
ring thereby increasing their polarity and limiting their 
cellular permeability (Spencer, 2003). Increased 
molecular weight of compounds 6 and 7 might also limit 
their cellular permeability. From the comparison of 
cytotoxic activity of compounds 1 and 3 on BGC-823 
cells, the reduced cytotoxic activity observed in 
compound 1 might be due to the additional methoxyl 
group at 4' position. Structure-activity relationship 
analysis of flavonols and flavones separated from C. 
bonduc suggests increased cytotoxic activity with the 
presentation of a hydroxyl group at 3' of the B ring and 
also with enhanced activity with methylation of the 3 
hydroxyl group at C ring.  
 
A number of bioactive flavonoids as well as other 
phytochemicals have been separated from C. bonduc with 
anticancer activity (Yadav et al., 2007; Yadav et al., 
2009); nevertheless, this is the first report on the isolation, 
purification and identification of compounds 2 to 7 from 
C. bonduc in literature. In addition, this is also the first 
report on the cytotoxic activity of compound 3, 7,4'-
Table S3: 1H and 13C-NMR spectral data for compounds 4 and 5 (δ in ppm, J in Hz) 
 
Compounds δC δH δC δH 4 5 
2 166.00 - 158.0 - 
3 103.82 6.54 (1H, s) 139.52 - 
4 183.85 - 180.01 - 
5 163.19 - 163.08 - 
6 100.09 6.20 (1H, d, J = 1.2) 99.75 6.20 (1H, d, J = 2.0) 
7 166.33 - 165.94 - 
8 94.97 6.44 (1H, br s) 94.70 6.39 (1H, d, J = 2.0) 
9 159.40 - 158.42 - 
10 105.28 - 105.83 - 
1' 123.64 - 122.88 - 
2' 114.11 7.38 (1H, overlap) 116.42 7.63 (1H, d, J = 2.0) 
3' 147.11 - 146.50 - 
4' 150.98 - 149.97 - 
5' 116.75 6.90 (1H, d, J = 8.4) 116.42 7.53 (1H, dd, J = 8.4) 
6' 120.28 7.38 (1H, overlap) 122.31 6.90 (1H, d, J = 8.4) 
3-OCH3 - - 60.52 3.78 (3H, s) 
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dihydroxy-3,11-dehydrohomoisoflavanone on BGC-823 
cells. Since flavonoids display a huge array of cellular 
activity, several mechanisms have been proposed for their 
cytotoxicity including inhibition of DNA topoisomerase 
I/II activity, increased generation of reactive species 
(Wang et al., 1999), decrease level of redox active 
proteins (Lu et al., 2006), DNA oxidation and 
fragmentation, regulation of heat-shock-protein 
expression, cell cycle arrest, modulation of 
survival/proliferation pathways and activation of 
proapoptotic cellular factors (Ramos, 2007). 
 
Flavonoids’ anti-cancer activity has been reportedly 
associated with induction of apoptosis, which is 
characterised by early mitochondrial dysfunction and 
endoplasmic reticulum-stress-induced signaling factors 
(Choi et al., 2011). From the reports of Huang et al. 
(2011), reduced cancer cell viability of an isoflavone, 
Osajin, isolated from medicinal plant was characterised 
by the release of cytochrome c into the cytosol, the 
gradual decline of mitochondrial transmembrane 
potential, down-regulation of glucose-regulated protein 
Bcl-2 and 78 kDa (anti-apoptotic factors), stimulation of 
the activities of caspases-3, -4, -8 and -9 and up-
regulation of Bax and Fas lig and (FasL) (pro-apoptotic 
factors). The ability of quercetin to promotes apoptosis in 
cancer cell by down-modulating the expression of heat 
shock protein 90, which, in turn, induces the suppression 
of development and cell death in prostate cancer cells 
while exercising no quantitative effect on normal prostate 
epithelial cells has been demonstrated (Aalinkeel et al., 
2008). 
  
CONCLUSIONS 
 
C. bonduc possesses cytotoxic activity; its petroleum 
ether and water fractions contain the major cytotoxic 
constituents. Compounds 1 to 5, all flavonoids, separated 
from C. bonduc were part of bioactive principles that 
mediate the cytotoxic activity of the plants. 
  
SUPPORTING INFORMATION 
 
Experimental procedure of purification and isolation of 
flavonoids and their 1D spectra data (tables S1-S4) are 
available as Supporting Information. 
Table S4: 1H and 13C-NMR spectral data for compounds 6 and 7 (δ in ppm, J in Hz) 
 
Compounds δC δH δC δH 6 7 
2 158.38 - 158.12 - 
3 135.31 - 134.30 - 
4 179.36 - 179.12 - 
5 163.00 - 162.90 - 
6 99.89 6.18 (1H, br s) 99.82 6.06 (1H, br s) 
7 165.96 - 165.50 - 
8 94.76 6.37 (1H, br s) 94.71 6.24 (1H, br s) 
9 15890 - 158.54 - 
10 105.61 - 105.80 - 
1' 122.58 - 122.90 - 
2' 132.20 8.01 (2H, d, J = 8.4) 132.01 7.92 (2H, d, J = 8.,5) 
3' 116.11 6.86 (2H, d, J = 8.4) 116.12 6.82 (2H, d, J = 8.5) 
4' 161.60 - 161.23 - 
5' 116.11 6.86 (2H, d, J = 8.4) 116.12 6.82 (2H, d, J = 8.5) 
6' 132.20 8.01 (2H, d, J = 8.4) 132.01 5.53 (1H, d, J = 7.0) 
1'' 104.64 5.16 (1H, d, J = 6.8) 101.22 5.53 (1H, d, J = 7.0) 
2'' 75.33 3.74 (1H, d, J = 4.8) 79.32 - 
3'' 77.52 3.48 (1H, t, J = 5.8) 77.90 - 
4'' 70.98 3.41 (1H, d, J = 8.2) 72.22 - 
5'' 67.20 3.76 (2H,s, J = 4.6) 66.90 - 
1''' - - 102.53 5.21 (1H, br s) 
2''' - - 71.34 - 
3''' - - 72.33 - 
4''' - - 74.01 - 
5''' - - 70.01 - 
6''' - - 17.73 - 
1H NMR and 13C NMR were recorded at 500 and 125 MHz respectively in DMSO-d6. 
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Table 1: Cytotoxic activity of solvent fractions and 
compounds of ethanolic extract of C. bonduc   
 
Samples/ 
Compounds 
IC50 (µg/mL) IC50 (µg/mL) 
Hela cells lines BGC 823 cell lines 
Pet. Ether a32.00 NA 
Water a30.14 NA 
75% Et NA NA 
n-Butanol NA NA 
Ethyl ac. NA NA 
1 #5.88 NA 
2 #8.69 NA 
3 #5.91 #6.45 
4 #5.27 NA 
5 ##0.81 NA 
6 NA NA 
7 NA NA 
Taxol ##1.022 ##0.15 
 
IC50 is 50 % inhibitory concentration; Pet. ether, 75% Et, 
Ethyl ac. represent petroleum ether, 75% ethanol (crude) 
and ethyl acetate extracts respectively. ##, # & a signify 
very strong, strong and weak cytotoxicity activities of 
samples while NA signify not applicable. The values were 
in triplicates. 
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